RobertLuther III (Rob)

Of Counsel

Washington + 1.202.879.3785

Rob Luther has served at high levels in all three branches of the United States federal government. His practice focuses on strategic counseling, regulatory matters, and litigation. He counsels clients in advance of Congressional, agency, and administrative hearings and has significant experience advising individuals navigating the oversight and confirmation processes before the United States Senate.

Prior to joining Jones Day in 2019, Rob served as Associate Counsel to the President in the White House Counsel's Office. The New York Times Magazine referred to his work on judicial selection throughout this period as "unique in White House history." Before joining the Administration, Rob served as counsel on the United States Senate Judiciary Committee, where he advised then-Senator Jeff Sessions on judicial nominations and constitutional law, and served as a law clerk to Judge Daniel A. Manion of the U.S. Court of Appeals for the Seventh Circuit.

Before entering public service, Rob actively litigated before Virginia courts and tribunals. In his pro bono practice, he has successfully represented students charged in disciplinary proceedings and nonviolent felons seeking the restoration of their constitutional rights in state and federal courts throughout the Commonwealth.

Rob also serves on the faculty of the Antonin Scalia Law School at George Mason University, where he teaches courses on legal writing and the federal judiciary. He previously taught at William & Mary Law School. He frequently speaks on the legal profession, federal judicial selection, and constitutional law in public forums and has published widely on these topics.


  • U.S. Chamber of Commerce files amicus brief in Anti-Injunction Act caseJones Day filed an amicus brief on behalf of the United States Chamber of Commerce in support of certiorari in a lawsuit challenging certain regulatory guidance by the Internal Revenue Service.
  • CEO testifies before Congressional subcommitteeJones Day prepared the CEO of a Fortune 500 company for testimony before a subcommittee of the U.S. House of Representatives.
  • Biotechnology company persuades FDA to lift clinical hold on experimental gene therapyJones Day represented a biotechnology company in a lawsuit against the Food and Drug Administration (FDA) for placing a clinical hold on the company’s experimental gene therapy.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.